Condition
Graft -Versus-host-disease
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (2)
Trial Status
Not Yet Recruiting1
Recruiting1
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07297914Phase 2Not Yet Recruiting
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
NCT07246031Phase 2RecruitingPrimary
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
NCT02055625Phase 1WithdrawnPrimary
Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease
Showing all 3 trials